Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. (“Ensign” or the ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or ...
Kaplan Fox and (2) that, as a result, the Company’s $1 billion monthly funded volume target was likely to be deferred. CLICK ...
Kaplan Fox (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against FuelCell Energy, Inc. (“FuelCell” or ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE: HYLN) on behalf of investors that purchased or ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. (“Ardelyx” or the ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” ...
Kaplan Fox (b) in an effort to boost sales in the short-term, Simply Good had offered discounts and engaged in other ...
Kaplan Fox (2) that, as a result, the Company was experiencing a significant drop in student starts relative to enrollment; ...
Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Taboola.com Ltd. (“Taboola.com” or ...
Management call today at 3.30 pm CEST Newron received the anticipated FDA written communication on clinical hold at U.S. study centers and is reviewing feedback and preparing its response ENIGMA-TRS 1 ...